Insider · CIK 0001588836
Thomas S Elley
Files at FUSB (FIRST US BANCSHARES, INC.). First filing -, latest -.
In brief
Thomas S Elley files SEC Form 4 as CFO at FUSB (FIRST US BANCSHARES, INC.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Thomas S Elley has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 17 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jul 8, 2026 | FUSB FIRST US BANCSHARES, INC. | MOption exercise Common Stock, $.01 par value | +6,300 | $11.71 | $74k | 43,080 | Jul 9, 2026 |
| Jul 8, 2026 | FUSB FIRST US BANCSHARES, INC. | FTax withholding Common Stock, $.01 par value | -4,924 | $16.95 | $83k | 38,156 | Jul 9, 2026 |
| Jul 8, 2026 | FUSB FIRST US BANCSHARES, INC. | MOption exercise Stock Option (right to buy)derivative | -6,300 | $0.00 | $0 | 0 | Jul 9, 2026 |
| Jun 26, 2026 | FUSB FIRST US BANCSHARES, INC. | MOption exercise Common Stock, $.01 par value | +7,000 | $14.11 | $99k | 43,000 | Jun 29, 2026 |
| Jun 26, 2026 | FUSB FIRST US BANCSHARES, INC. | FTax withholding Common Stock, $.01 par value | -6,220 | $16.75 | $104k | 36,780 | Jun 29, 2026 |
| Jun 26, 2026 | FUSB FIRST US BANCSHARES, INC. | MOption exercise Stock Option (right to buy)derivative | -7,000 | $0.00 | $0 | 0 | Jun 29, 2026 |
| Feb 9, 2026 | FUSB FIRST US BANCSHARES, INC. | AGrant or award Common Stock, $.01 par value | +3,300 | $0.00 | $0 | 36,000 | Feb 10, 2026 |
| Nov 13, 2025 | FUSB FIRST US BANCSHARES, INC. | MOption exercise Common Stock, $.01 par value | +6,100 | $8.30 | $51k | 37,063 | Nov 14, 2025 |
| Nov 13, 2025 | FUSB FIRST US BANCSHARES, INC. | FTax withholding Common Stock, $.01 par value | -4,363 | $13.90 | $61k | 32,700 | Nov 14, 2025 |
| Nov 13, 2025 | FUSB FIRST US BANCSHARES, INC. | MOption exercise Common Stock, $.01 par valuederivative | +6,100 | $0.00 | $0 | 0 | Nov 14, 2025 |
| Feb 10, 2025 | FUSB FIRST US BANCSHARES, INC. | AGrant or award Common Stock, $.01 par value | +3,300 | $0.00 | $0 | 30,963 | Feb 11, 2025 |
| Dec 2, 2024 | FUSB FIRST US BANCSHARES, INC. | MOption exercise Common Stock, $.01 par value | +2,900 | $8.23 | $24k | 29,765 | Dec 3, 2024 |
| Dec 2, 2024 | FUSB FIRST US BANCSHARES, INC. | FTax withholding Common Stock, $.01 par value | -2,102 | $13.47 | $28k | 27,663 | Dec 3, 2024 |
| Dec 2, 2024 | FUSB FIRST US BANCSHARES, INC. | MOption exercise Stock Option (right to buy)derivative | -2,900 | $0.00 | $0 | 0 | Dec 3, 2024 |
| Nov 15, 2024 | FUSB FIRST US BANCSHARES, INC. | MOption exercise Common Stock, $.01 par value | +3,000 | $8.23 | $25k | 29,124 | Nov 18, 2024 |
| Nov 15, 2024 | FUSB FIRST US BANCSHARES, INC. | FTax withholding Common Stock, $.01 par value | -2,259 | $12.65 | $29k | 26,865 | Nov 18, 2024 |
| Nov 15, 2024 | FUSB FIRST US BANCSHARES, INC. | MOption exercise Stock Option (right to buy)derivative | -3,000 | $0.00 | $0 | 2,900 | Nov 18, 2024 |
Questions about Thomas S Elley
Answered from the filings on this page, as of the latest one.
Is Thomas S Elley buying or selling?
Thomas S Elley has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Thomas S Elley's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Thomas S Elley has 0.
Where does Thomas S Elley file Form 4?
Thomas S Elley has filed Form 4 at FUSB (FIRST US BANCSHARES, INC.) as SEVP,CFO,Trea,Ast Sec-FUSB. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.